Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)
Clinical trial NCT02437591 · COMPLETED
Trial details
- NCT number
- NCT02437591
- Sponsor
- Astellas Pharma Europe Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-13
- Primary completion
- 2016-05-12
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.